GRAIL, Inc. (GRAL) financial statements and ratios from SEC XBRL: revenue $0.2B (TTM), net margin -277.5%, revenue growth 17.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $147.17M |
| Revenue (TTM) | $0.2B |
| Net Margin | -277.5% |
| Operating Margin (TTM) | -348.7% |
| Revenue Growth (YoY) | 17.2% |
| EPS Growth (YoY) | -82.5% |
| FCF Growth (YoY) | -48.5% |
| Price / Book | 1.42 |
| Price / Sales | 24.53 |
| FCF Yield | -16.7% |
| Altman Z-Score | 0.78 (distress) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
GRAL overview · GRAL earnings · GRAL KPIs · GRAL documents · GRAL ownership · GRAL peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.